aTyr Pharma - Home
aTyr Pharma, Inc. is a biopharmaceutical company focused on an entirely new class of biologics, the Physiocrines™.
aTyr Pharma’s drug engine for new biotherapeutics consists of Physiocrines™, which are novel proteins derived from the family of tRNA synthetases. Physiocrines have novel cell signaling activities distinct from the protein synthesis activities commonly associated with the tRNA synthetases. These proteins are being developed as novel therapeutics to treat a variety of diseases in therapeutic areas such as inflammation, hematopoietic and metabolic disorders.